PlainRecalls
FDA Devices Moderate Class II Ongoing

QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 Tests

Reported: May 1, 2024 Initiated: March 5, 2024 #Z-1637-2024

Product Description

QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 Tests

Reason for Recall

There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the positivite test line may not be visible/ hidden under the cassette of the test device thus potentially leading to a false negative result.

Details

Recalling Firm
Quidel Corporation
Units Affected
31,140 units
Distribution
US: AK AL AR AZ CA CO CT DC FL GA HI IA ID IL IN KS KY LA MA MD MI MN MO MT NC ND NE NH NJ NV NY OH OK OR PA SC SD TN TX UT VA WA WI WV OUS: United Arab Emirates, Belgium, Canada, Chile, China, Germany, Spain, United Kingdom, Ireland, Italy, South Korea, Lithuania, Qatar
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 Tests. Recalled by Quidel Corporation. Units affected: 31,140 units.
Why was this product recalled?
There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the positivite test line may not be visible/ hidden under the cassette of the test device thus potentially leading to a false negative result.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 1, 2024. Severity: Moderate. Recall number: Z-1637-2024.